Reuters: FDA Warns Of Cybersecurity Risk With Certain Medtronic Insulin Pumps The U.S. Food and Drug Administration on Tuesday warned that certain types of insulin pump systems manufactured by Medtronic were vulnerable to cyberattacks and that hackers could potentially hamper insulin delivery by accessing the device. The agency issued a cybersecurity risk alert for the Medtronic MiniMed 600 Series insulin pump system, which has several components including an insulin pump and a blood glucose meter that communicate wirelessly. (9/21) In other pharmaceutical industry news — Houston Chronicle: TMC Plans To Build Massive Biomanufacturing, Distribution Center The Texas Medical Center plans to build a 500-acre biomanufacturing and medical supplies distribution center in Houston, a project that represents the latest push to establish the city as a premier hub for life sciences.